Javelin Medical

Javelin Medical Overview

Javelin Medical is developing a device to prevent stroke in individuals with abnormal heart rhythm (atrial fibrillation). The company's device, Vine, is a permanent filter implanted in the carotid arteries designed to prevent strokes from occurring by intercepting blood clots. Vine is implanted through a thin needle in a short, simple procedure. It is currently available for individuals with atrial fibrillation through participation in the CAPTURE II study in several European countries.

Latest News

May 11, 2019 · www.medpagetoday.com

growth-positive

Novel Carotid Filter Aims for Stroke Prevention in Afib

A pilot trial showed that stroke prophylaxis with a novel permanent filter implanted in the carotid arteries is feasible for high-risk atrial fibrillation (Afib) patients. The Vine coil filter, developed by Javelin Medical, was successfully placed in 92% of patients without major adverse events. The device caught emboli in four patients, which were dissolved with subcutaneous heparin. The trial was not powered to assess clinical outcomes, but a single patient had two minor strokes unrelated to the device. The CAPTURE trial included 25 patients who were unsuitable for oral anticoagulants. The filter is made of super-elastic nitinol wire and has a circular cross-section. The trial was supported by Javelin Medical and a grant from the Czech Ministry of Health.

Customers

Funding

Team Members

3

Employees: 11-50

Web & Social Links

Locations

Ha-Kidma Street 27, Yokne'am Illit, Israel

Photos & Videos

No files yet

Javelin Medical Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info